Riskpilot← Back to searchSign inGet full accessFOCUSCARE DENMARK ApS.
APSActiveCVR 14653538Østervangsvej 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19905 employees
Revenue 2025
DKK 5,6M
+10% vs 2024
EBITDA margin
47.0%
+28% vs 2024
Equity ratio
57.9%
Financial strength
Net profit 2025
DKK 2,1M
+24% vs 2024
| Revenue | DKK 5,6M | +10% |
| EBITDA | DKK 2,6M | +28% |
| Net profit | DKK 2,1M | +24% |
| Total assets | DKK 5,8M | -6% |
| Equity | DKK 3,4M | +9% |
| Employees | 5 | — |
Legal name
FOCUSCARE DENMARK ApS.
CVR number
14653538
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. september 1990
Share capital
DKK 200.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene
Company purpose
Selskabets formål er at drive handel og industri
Address
Østervangsvej 21
Phone
+4549261399
Email
info@focuscare.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.235 | 4.821 | 4.936 | 2.438 | 2.191 | 2.797 | 2.759 | 3.022 | 3.257 | 3.278 | 2.957 | 4.692 | 5.112 | 5.618 |
| Staff expenses | -2.278 | -2.739 | -2.493 | -2.242 | -1.425 | -1.857 | -1.856 | -2.372 | -2.158 | -2.241 | -2.489 | -2.962 | -3.050 | -2.950 |
| EBITDA | 2.113 | 2.082 | 2.475 | 218 | 695 | 825 | 1.036 | 837 | 1.099 | 1.037 | 467 | 1.730 | 2.062 | 2.640 |
| Depreciation & amort. | 191 | -215 | -289 | -282 | -219 | -271 | -310 | -170 | -63 | -63 | -58 | -3 | -3 | -3 |
| EBIT | 1.922 | 1.868 | 2.186 | -64 | 475 | 553 | 726 | 667 | 1.035 | 973 | 409 | 1.726 | 2.059 | 2.637 |
| Net financials | -36 | -23 | -63 | -75 | -31 | -19 | -27 | -27 | -1 | -11 | -66 | -22 | 84 | 14 |
| Profit before tax | 1.886 | 1.845 | 2.123 | -139 | 444 | 534 | 699 | 640 | 1.034 | 962 | 369 | 1.710 | 2.143 | 2.651 |
| Tax | 477 | 469 | 518 | -35 | 97 | 95 | 161 | 141 | 229 | 214 | 81 | 377 | 473 | 585 |
| Net profit | 1.409 | 1.376 | 1.605 | -103 | 347 | 439 | 539 | 499 | 805 | 748 | 287 | 1.334 | 1.670 | 2.066 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.461 | 4.650 | 5.683 | 5.567 | 4.032 | 4.116 | 3.536 | 3.424 | 4.678 | 4.698 | 4.511 | 5.646 | 6.213 | 5.828 |
| Equity | 1.844 | 1.720 | 1.825 | 1.221 | 1.568 | 1.657 | 1.796 | 1.923 | 2.220 | 2.165 | 1.672 | 2.718 | 3.088 | 3.372 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49 | 118 | 74 | 74 | 0 | 0 | 0 |
| Short-term debt | 2.560 | 2.868 | 3.775 | 4.298 | 2.378 | 2.410 | 1.681 | 1.388 | 2.307 | 2.440 | 2.759 | 2.923 | 3.119 | 2.455 |
| Total debt | 2.560 | 2.868 | 3.775 | 4.298 | 2.378 | 2.410 | 1.681 | 1.438 | 2.425 | 2.514 | 2.833 | 2.923 | 3.119 | 2.455 |
EBITDA margin
47.0%
This company
15.8%
Market median
+197% vs market
20122025
Equity ratio
57.9%
This company
38.2%
Market median
+52% vs market
20122025
Return on equity
61.3%
This company
18.4%
Market median
+233% vs market
20122025
Net profit margin
36.8%
This company
8.1%
Market median
+354% vs market
20122025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20122025
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ED Management | Management | 2022 | — | — |
EH | Audit | 1990 | — | — |
KL Management | Management | 1996 | — | — |
IB Founder | Founder | 1990 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KAJ LUND HOLDING ApS | Company | 100.0% | 100.0% | 2005 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KAJ LUND HOLDING ApS
FOCUSCARE DENMARK ApS. Board members of FOCUSCARE DENMARK ApS. also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Else Damsgaard Due | Management | 0 companies |
| Eskild Herbert Schjerning | Audit | 0 companies |
| Kaj Lund | Management | 0 companies |
| Inge-Lise Balduin Sørensen | Founder | 0 companies |